HEALTH OF WOMAN. 2020.8(154): 54–58; doi 10.15574/HW.2020.154.54
Lakhno I. V.¹, Tkachov A. E.², Grischenko O. V.^1
1Kharkiv Medical Academy of Postgraduate Education
²City Perinatal Center of Kharkiv City Council

The inflammatory diseases of the pelvic organs are known to be one of the important problems of modern gynecology, which is due to the high frequency of chronicity of the process and a large number of complications. The article provides a theoretical and practical substantiation of the use of the drugs Rheosorbilact and Grandazol to increase the efficacy of empirical therapy in patients with acute salpingo-oophoritis.
The objective: study of the effectiveness of the use of hyperosmolar combined solution of sorbitol with a balanced content of electrolytes for low-volume infusion therapy (Rheosorbilact) and a solution of levofloxacin 2.5 mg and ornidazole 5 mg (Grandazole) in the treatment of women with acute PID.
Materials and methods. Totally 98 women of reproductive age were examined and divided into three clinical groups. The I (control) group included 30 healthy women. In group II (comparison), 33 patients with acute bilateral adnexitis were included, who were prescribed traditional treatment. In group III (main) group, there were 35 women who were additionally prescribed Rheosorbilact and Grandazole was used as an antibacterial agent.
Results. A survey of women with acute bilateral adnexitis found that among all clinical characteristics the most common were: lower abdominal pain (89.7%), abnormal vaginal discharge (88.2%), and fever (83.8%). The variables of the level of C-reactive protein, the number of leukocytes, and the value of the resistance index in the ovarian arteries were elevated in the study population before treatment, respectively: 52.4±8.3 mg/l, 11.8±2.2×10⁹/l, 1.4±0.2, which differed from the control values (p<0.05). The study of the pseudo-R² Nagelkerke confirmed the relationship between increased resistance index and lower abdominal pain, abnormal vaginal discharge and fever with high sensitivity (88,2%) and insufficient specificity (60.4%).
Thus, in women with acute salpingo-oophoritis, the presence of inflammatory symptoms (even in the absence of Doppler data) is an indication for the use of infusions of vasotrophic drugs with the hemorheological action.The priority effect of this method of treatment was the optimization of hemodynamics in the large vessels of the small pelvis, which provided the effective delivery and accumulation of antibacterial drugs in the inflammation focus.
Conclusion. The specified combination of drugs Rheosorbilact and Grandazole has demonstrated the maximum clinical effect, which justifies the possibility of widespread use of this method of therapy.
Keywords: inflammatory diseases of the pelvic organs, Doppler ultrasound, treatment, Rheosorbilact, Grandazole.

REFERENCES

1. Lakhno IV, Tkachov AE. 2020. Reosorbilakt pokrashchuie efektyvnist empirychnoi terapii zapalnykh zakhvoriuvan orhaniv maloho taza. Medychni aspekty zdorovia zhinky 2(131):46-49.

2. Cueva F, Caicedo A, Hidalgo PA. 2020. Need for Standardization of the Diagnosis and Treatment of Pelvic Inflammatory Disease: Pilot Study in an Outpatient Clinic in Quito, Ecuador. Infect Dis Obstet Gynecol. 2020:5423080. https://doi.org/10.1155/2020/5423080; PMid:32454581 PMCid:PMC7232719

3. Curry A, Williams T, Penny ML. 2019. Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. Review Am Fam Physician. 100(6):357-364.

4. Di Tucci C, Di Mascio D, Schiavi MC et al. 2018. Pelvic Inflammatory Disease: Possible Catches and Correct Management in Young Women. Case Rep Obstet Gynecol. 2018:5831029. https://doi.org/10.1155/2018/5831029; PMid:30112235 PMCid:PMC6077411

5. Maatouk I, Assi M. 2019. A case of Mycoplasma genitalium possible resistance in a woman. 6(2):116-117. https://doi.org/10.1016/j.ijwd.2019.11.002; PMid:32258345 PMCid:PMC7105642

6. Mongkhon JM, Thach M, Shi Q et al. 2014. Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes Inflamm Res. 63(8):691-701. https://doi.org/10.1007/s00011-014-0742-4; PMid:24858301

7. Naqvi SAR, Drlica K. 2017. Fluoroquinolones as imaging agents for bacterial infection. Dalton Trans. 46(42):14452-14460. https://doi.org/10.1039/C7DT01189J; PMid:28920628 PMCid:PMC5739321

8. Nomoto Y, Sawada S, Abe S et al. 2018. Sorbitol Minimizes Calcium Carbonate Scale Generation While Maintaining the Disinfection Effect of Heated Scallop-Shell Powder for Fresh Produce Biocontrol Sci. 23(4):157-165. https://doi.org/10.4265/bio.23.157; PMid:30584202

9. Özbay K, Deveci S. 2011. Relationships between transvaginal colour Doppler findings, infectious parameters and visual analogue scale scores in patients with mild acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol. 156(1):105-8. https://doi.org/10.1016/j.ejogrb.2010.12.030; PMid:21269753

10. Rafeek R, Carrington CVF, Gomez A et al. 2018. Xylitol and sorbitol effects on the microbiome of saliva and plaque. J Oral Microbiol. 11(1):1536181. https://doi.org/10.1080/20002297.2018.1536181; PMid:30598728 PMCid:PMC6225370

11. Romosan G, Valentin L. 2014. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature. Arch Gynecol Obstet. 289(4):705-14. https://doi.org/10.1007/s00404-013-3091-6; PMid:24287707

12. Safrai M, Rottenstreich A, Shushan A et al. 2020. Risk factors for recurrent Pelvic Inflammatory Disease. 244:40-44. https://doi.org/10.1016/j.ejogrb.2019.11.004; PMid:31734623

13. van der Hoven B, van Pelt H, Swart EL et al. 2010. Noninvasive functional liver blood flow measurement: comparison between bolus dose and steady-state clearance of sorbitol in a small-rodent model. Am J Physiol Gastrointest Liver Physiol. 298(2):G177-81. https://doi.org/10.1152/ajpgi.90688.2008; PMid:19940028

14. Verdon R. 2019. Treatment of uncomplicated pelvic inflammatory disease: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines. Gynecol Obstet Fertil Senol. 47(5):418-430.

15. Zhivolupov SA, Samartsev IN, Rashidov NA et al. 2013. Metabolic therapy in neurology. Zh Nevrol Psikhiatr Im S S Korsakova. 113(7):37-41.